DRUG/DEVICE STATUS DISCLOSURE

Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with applicable law.

Baylor College of Medicine requires that all faculty/presenters disclose an unlabeled use or investigational use of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use.  Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

DISCLOSURE POLICY

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.  BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In  accordance  with  the  ACCME  Standards for  Commercial Support, BCM has  implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME’s validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions.  If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly. 

All of the relevant financial relationships listed for these individuals have been mitigated.

FACULTY

Ali Asghar-Ali, MD - Activity Director
Associate Professor, Psychiatry & Behavioral Sciences
Baylor College of Medicine
Disclosure: Nothing to disclose

Nancy Wilson - Co-Activity Director
Faculty, Department of Medicine
Baylor College of Medicine
Disclosure: Nothing to disclose

Peer Reviewer

In August 2022, this continuing medical education online enduring activity was reviewed by Ashish Sarangi, M.D. To ensure the continued scientific relevance of this enduring material, its content will be reviewed again in August 2024.

Ashish Sarangi, M.D.
Fellow Physician PGY5
Baylor College of Medicine
Disclosure: Nothing to disclose